Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia

Clinical trial NCT03697707 · UNKNOWN

Trial details

NCT number: NCT03697707
Sponsor: Mendus
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Remission

Start date: 2018-10-15
Primary completion: 2023-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.